Alkermes Plc (ALKS)
31.91
-0.09
(-0.28%)
USD |
NASDAQ |
Feb 20, 16:00
31.86
-0.05
(-0.16%)
After-Hours: 20:00
Alkermes SG&A Expense (Quarterly) : 171.77M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 52.64M |
| Krystal Biotech, Inc. | 41.45M |
| Assertio Holdings, Inc. | 10.74M |
| Amicus Therapeutics, Inc. | 117.08M |
| Jazz Pharmaceuticals Plc | 530.65M |